Appointment of Dr. Paul Ford MD, PhD as Senior Clinical Development Advisor

Exciting Announcement: Appointment of Dr. Paul Ford MD, PhD as Senior Clinical Development Advisor

We are thrilled to welcome Dr. Paul Ford MD, PhD to Qureight's Scientific Advisory Committee!

Dr. Ford is a UK-trained pulmonologist with deep expertise in clinical drug development solutions. After a successful academic tenure at Imperial College London under the mentorship of Prof. Sir Peter Barnes, Paul has built an impressive career in the pharmaceutical industry. His experience includes leadership roles at Novartis, Galecto, Inc., Galapagos, and PureTech Health, where he has made significant contributions, including leading 4 clinical IPF candidates into the clinic.

Having followed Qureight’s growth since the start, Paul is now stepping into a more formal role with us, bringing his wealth of experience and expertise in drug development and pulmonology to the team. As Paul states:

"After being involved with Qureight since its inception and seeing the technology platform grow to where it is, I am delighted to be joining them in a more formal role. I have long believed imaging will solve several issues we have with endpoints and patient selection in clinical studies, as has readily been shown in interstitial lung disease."

We are excited to work alongside Dr. Ford as we continue to leverage our cutting-edge technology to transform clinical trials and improve patient outcomes, especially in areas like interstitial lung disease.

Welcome aboard, Paul!